• Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos

Budget News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17465.15 -113.08 NIFTY 5222.30 -40.50
 

Natco Pharma Nine Months, Natco Pharma Financial Statement & Accounts

Natco Pharma

BSE: 524816  |  NSE: NATCOPHARM  |  ISIN: INE987B01018  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Nine Months of Natco Pharma

------------------- in Rs. Cr. -------------------
Dec '05 Dec '06 Dec '07 Dec '08 Dec '09
Sales Turnover 122.41 139.57 171.09 192.55 216.25
Other Income 24.09 23.81 13.25 12.16 19.66
Total Income 146.50 163.38 184.34 204.71 235.91
Total Expenses 116.05 120.77 139.66 153.63 171.39
Operating Profit 6.36 18.80 31.43 38.92 44.86
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- 1.65 3.96 0.30
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 30.45 42.61 44.68 51.08 64.52
Interest 6.16 5.28 7.03 10.45 11.46
PBDT 24.29 37.33 39.30 44.59 53.36
Depreciation 5.00 5.84 6.67 8.55 9.75
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 19.29 31.49 32.63 36.04 43.61
Tax 0.12 4.97 4.79 5.88 10.27
Net Profit 19.17 26.52 27.84 30.16 33.34
Prior Years Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share 7.11 9.76 9.96 10.76 11.84
Book Value -- -- -- -- --
Equity 26.97 27.17 27.94 28.04 28.15
Reserves -- -- -- -- --
Face Value 10.00 10.00 10.00 10.00 10.00
Source : Religare Technova
Explore Natco Pharma connections